Thomas Lumsden
Papers
1
Total Citations
52
H-Index
1
About
Thomas Lumsden is a prominent urological researcher whose work centers on advancing treatment paradigms for clinically localized prostate cancer. His major contribution lies in critically evaluating emerging focal ablative therapies against standard management options, particularly through his landmark 2021 systematic review—cited 52 times—which exposed limitations in existing evidence and provided actionable recommendations for clinical practice and future research. This work has been instrumental in guiding urologists toward more evidence-based, patient-tailored approaches, highlighting the need for robust comparative studies. Lumsden’s research bridges the gap between innovative, less invasive treatments and the rigorous standards of oncological safety, making him a key voice in the ongoing debate over prostate cancer management. His influence extends beyond citation counts, as his recommendations have shaped clinical guidelines and spurred further investigation into focal therapy’s role. For students and researchers, Lumsden exemplifies how systematic, critical analysis can drive meaningful progress in a field where treatment decisions carry profound implications for patient quality of life and outcomes.
Research Focus
Key Achievements
Top Papers
- 1